Device typeLipopolyssacharide (LPS) IVD, kit, chemiluminescent immunoassay: A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of lipopolysaccharides, also known as endotoxin, in a clinical specimen, using a chemiluminescent immunoassay method. It is typically used to determine endotoxin activity, to aid in the diagnosis and treatment of disorders associated with exposure to bacterial endotoxin (e.g., sepsis and post-traumatic/postsurgical infection).
FDA categoryAssay, Endotoxin Activity, Chemiluminescent
Device IDB173EAASTNA0
Catalog numberEAAST-NA
Single useYes
MRI safetyLabeling does not contain MRI Safety Information